Skip to main content

Ireland Places Temporary Ban on Transvaginal Mesh

Ireland Places Temporary Ban on Transvaginal Mesh

Ireland Places Temporary Ban on Transvaginal Mesh

Introduction

Just a week after the United Kingdom's National Health Services (NHS) declared a temporary ban on the use of transvaginal mesh, Ireland's Chief Medical Officer Simon Harris has also announced a temporary suspension on the use of the mesh stating “understandable public and patient anxiety” concerning the safety of the implants.

Harris stated, "there are understandable public and patient anxiety about the ongoing safety of mesh devices following the considerable publicity that this issue has received, and this has been heightened by recent developments in the NHS. A pause on the use of mesh procedures, pending confirmation by the Executive that the key recommendations below have been implemented, is now considered proportionate and necessary to provide public assurance that these procedures are being carried out in accordance with internationally accepted good practice.” The ban will remain intact till Ireland's Health Service Executive (HSE) can provide possible recommendations related to surgical training, informed consent and an agreed dataset development on the mesh products.

Lawsuits against the manufacturers of Transvaginal mesh (TVM) continue to be filed in the U.S. District Courts, over design flaws causing severe internal injuries in several women.  Ethicon, C.R. Bard, Boston Scientific are some of the defendants in the TVM litigation, overlooked by Judge Joseph R. Goodwin in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!